Compound details
Dihydrolipoate
| Compound ID | CDAMM00463 |
|---|---|
| Common name | Dihydrolipoate | IUPAC name | 6,8-bis(sulfanyl)octanoic acid |
| Molecular formula | C8H16O2S2 |
| Retention time | 10.12 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 209.067 | Theoretical mz | 209.066 |
| Error | 5.38 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 9.5369 |
| Inchi key | IZFHEQBZOYJLPK-UHFFFAOYNA-N |
|---|---|
| Smiles | O=C(O)CCCCC(S)CCS |
| Superclass | Lipids and lipid-like molecules |
| Class | Fatty Acyls |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P22303 | ACHE | Acetylcholinesterase | T30082 | SwissTargetPrediction |
| P09874 | PARP1 | Poly [ADP-ribose] polymerase-1 | T06273 | SwissTargetPrediction |
| Q8TDS4 | HCAR2 | Hydroxycarboxylic acid receptor 2 | T88185 | SwissTargetPrediction |
| P12821 | ACE | Angiotensin-converting enzyme | T98311 | SwissTargetPrediction |
| P00797 | REN | Renin | T61622 | SwissTargetPrediction |
| P24046 | GABRR1 | GABA receptor rho-1 subunit | T99665 | SEA |
| P15144 | ANPEP | Aminopeptidase N | T67272 | SwissTargetPrediction |
| O75899 | GABBR2 | GABA-B receptor | T42446 | SEA |
| P00734 | F2 | Thrombin | T94033 | SwissTargetPrediction |
| P48066 | SLC6A11 | GABA transporter 3 | T38200 | SEA |
| O75899 | GABBR2 | GABA-B receptor | T42446 | SEA |
| Q14833 | GRM4 | Metabotropic glutamate receptor 4 | T99402 | SwissTargetPrediction |
| Q4U2R8 | SLC22A6 | Solute carrier family 22 member 6 (by homology) | T70680 | SEA |
| P15121 | AKR1B1 | Aldose reductase | T26623 | SwissTargetPrediction |
| Q9H3R0 | KDM4C | Lysine-specific demethylase 4C | T73863 | SEA |
| P10145 | CXCL8 | Interleukin-8 | T22658 | SwissTargetPrediction |
| Q5T7T8 | COX1 | Prostaglandin G/H synthase 1 | T60529 | SwissTargetPrediction |
| P35354 | PTGS2 | Cyclooxygenase-2 | T66665 | SwissTargetPrediction |
| P42330 | AKR1C3 | Aldo-keto-reductase family 1 member C3 | T60857 | SwissTargetPrediction |
| Q9H4A4 | RNPEP | Aminopeptidase B | T57818 | SEA |
| O75164 | KDM4A | Lysine-specific demethylase 4A | T18904 | SEA |
| Q96IY4 | CPB2 | Carboxypeptidase B2 isoform A | T98022 | SwissTargetPrediction |
| O15229 | KMO | Kynurenine 3-monooxygenase | T50973 | SwissTargetPrediction |
| Q07075 | ENPEP | Aminopeptidase A | T31956 | SwissTargetPrediction and SEA |
| P15090 | FABP4 | Fatty acid binding protein adipocyte | T07217 | SwissTargetPrediction |
| Q07869 | PPARA | Peroxisome proliferator-activated receptor alpha | T86591 | SwissTargetPrediction |
| Q01469 | FABP5 | Fatty acid binding protein epidermal | T21507 | SwissTargetPrediction |
| O14842 | FFAR1 | Free fatty acid receptor 1 | T25608 | SwissTargetPrediction |
| Q04609 | FOLH1 | Glutamate carboxypeptidase II | T97071 | SwissTargetPrediction |
| P11473 | VDR | Vitamin D receptor | T34234 | SwissTargetPrediction |
| Q8TDU6 | GPBAR1 | G-protein coupled bile acid receptor 1 | T86273 | SwissTargetPrediction |
| P06746 | POLB | DNA polymerase beta (by homology) | T06958 | SwissTargetPrediction |
| P14174 | MIF | Macrophage migration inhibitory factor | T39977 | SwissTargetPrediction |
| P27695 | APEX1 | DNA-(apurinic or apyrimidinic site) lyase | T13348 | SwissTargetPrediction |
| Q9P1W9 | PIM2 | Serine/threonine-protein kinase PIM2 | T07279 | SwissTargetPrediction |
| Q96S37 | SLC22A12 | Solute carrier family 22 member 12 | T86057 | SwissTargetPrediction |
| Q9Y5Y4 | PTGDR2 | G protein-coupled receptor 44 | T61722 | SwissTargetPrediction |
| P20701 | ITGAL | Intercellular adhesion molecule (ICAM-1), Integrin alpha-L/beta-2 | T35640 | SwissTargetPrediction |
| P0DMV8 | HSPA1A | Heat shock 70 kDa protein 1 | T49639 | SwissTargetPrediction |
| P53779 | MAPK10 | c-Jun N-terminal kinase 3 | T85421 | SwissTargetPrediction |
| P25098 | GRK2 | G-protein coupled receptor kinase 2 | T62548 | SwissTargetPrediction |
| Q9UGN5 | PARP2 | Poly [ADP-ribose] polymerase 2 | T40812 | SwissTargetPrediction |
| Q9BYF1 | ACE2 | Angiotensin-converting enzyme 2 | T27889 | SwissTargetPrediction |
| O15382 | BCAT2 | Branched-chain-amino-acid aminotransferase, mitochondrial | T94788 | SwissTargetPrediction |
| P42892 | ECE1 | Endothelin-converting enzyme 1 | T50970 | SwissTargetPrediction |
| P25101 | EDNRA | Endothelin receptor ET-A | T23499 | SwissTargetPrediction |
| P15085 | CPA1 | Carboxypeptidase A1 | T33966 | SwissTargetPrediction |
| Q13258 | PTGDR | Prostanoid DP receptor | T68782 | SwissTargetPrediction |
| P24557 | TBXAS1 | Thromboxane-A synthase | T78356 | SwissTargetPrediction |
| Q8TDS5 | OXER1 | Oxoeicosanoid receptor 1 | T68834 | SwissTargetPrediction and SEA |
| O76074 | PDE5A | Phosphodiesterase 5A | T07663 | SwissTargetPrediction |
| P68400 | CSNK2A1 | Casein kinase II alpha | T51565 | SwissTargetPrediction |
| P19784 | CSNK2A2 | Casein kinase II alpha (prime) | T80526 | SwissTargetPrediction |
| P14735 | IDE | Insulin-degrading enzyme | T81900 | SwissTargetPrediction |
| Q6ZMT4 | KDM7A | Lysine-specific demethylase 7A/7B | T18784 | SEA |
| Q9Y3Q0 | NAALAD2 | NAALADase II | T70036 | SEA |
| O76083 | PDE9A | Phosphodiesterase 9A | T17852 | SwissTargetPrediction |
| Q04609 | FOLH1 | Glutamate carboxypeptidase II | T97071 | SEA |
| Q4U2R8 | SLC22A6 | Solute carrier family 22 member 6 (by homology) | T70680 | SEA |
| Q9UN88 | GABRQ | GABA(A) receptor theta | T15161 | SEA |
| P78329 | CYP4F2 | Cytochrome P450 4f | T82604 | SEA |
| O60603 | TLR2 | Toll-like receptor 2 | T82078 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T30082 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P22303 | ACHE |
| T30082 | DI0166 | Glaucoma | [ICD-11: 9C61] | P22303 | ACHE |
| T30082 | DI0282 | Myasthenia gravis | [ICD-11: 8C6Y] | P22303 | ACHE |
| T30082 | DI0313 | Oesophageal/gastroduodenal disorder | [ICD-11: DD90] | P22303 | ACHE |
| T30082 | DI0332 | Pediculosis | [ICD-11: 1G00] | P22303 | ACHE |
| T30082 | DI0421 | Unspecific substance harmful effect | [ICD-11: NE6Z] | P22303 | ACHE |
| T06273 | DI0006 | Acquired cutaneous blood vessel malformation | [ICD-11: EF20] | P09874 | PARP1 |
| T06273 | DI0143 | Fallopian tube cancer | [ICD-11: 2C74] | P09874 | PARP1 |
| T06273 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | P09874 | PARP1 |
| T06273 | DI0334 | Peritoneal cancer | [ICD-11: 2C51] | P09874 | PARP1 |
| T88185 | DI0203 | Inborn lipid metabolism error | [ICD-11: 5C52] | Q8TDS4 | HCAR2 |
| T98311 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P12821 | ACE |
| T98311 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P12821 | ACE |
| T61622 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P00797 | REN |
| T67272 | DI0351 | Psoriasis | [ICD-11: EA90] | P15144 | ANPEP |
| T42446 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | O75899 | GABBR2 |
| T42446 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | O75899 | GABBR2 |
| T42446 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | O75899 | GABBR2 |
| T42446 | DI0290 | Narcolepsy | [ICD-11: 7A20] | O75899 | GABBR2 |
| T94033 | DI0052 | Bleeding disorder | [ICD-11: GA20-GA21] | P00734 | F2 |
| T94033 | DI0091 | Coagulation defect | [ICD-11: 3B10] | P00734 | F2 |
| T94033 | DI0219 | Ischaemic/haemorrhagic stroke | [ICD-11: 8B20] | P00734 | F2 |
| T94033 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P00734 | F2 |
| T94033 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | P00734 | F2 |
| T94033 | DI0306 | Nutritional deficiency | [ICD-11: 5B50-5B71] | P00734 | F2 |
| T94033 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P00734 | F2 |
| T94033 | DI0405 | Thrombosis | [ICD-11: DB61-GB90] | P00734 | F2 |
| T38200 | DI0207 | Indeterminate colitis | [ICD-11: DD72] | P48066 | SLC6A11 |
| T42446 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | O75899 | GABBR2 |
| T42446 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | O75899 | GABBR2 |
| T42446 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | O75899 | GABBR2 |
| T42446 | DI0290 | Narcolepsy | [ICD-11: 7A20] | O75899 | GABBR2 |
| T99402 | DI0331 | Parkinsonism | [ICD-11: 8A00] | Q14833 | GRM4 |
| T70680 | DI0167 | Gout | [ICD-11: FA25] | Q4U2R8 | SLC22A6 |
| T70680 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | Q4U2R8 | SLC22A6 |
| T70680 | DI0310 | Ocular disease | [ICD-11: N.A.] | Q4U2R8 | SLC22A6 |
| T26623 | DI0298 | Neuropathy | [ICD-11: 8C0Z] | P15121 | AKR1B1 |
| T26623 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P15121 | AKR1B1 |
| T22658 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P10145 | CXCL8 |
| T60529 | DI0141 | Eye anterior segment structural developmental anomaly | [ICD-11: LA11] | Q5T7T8 | COX1 |
| T60529 | DI0145 | Female pelvic pain | [ICD-11: GA34] | Q5T7T8 | COX1 |
| T60529 | DI0188 | Hyper-lipoproteinaemia | [ICD-11: 5C80] | Q5T7T8 | COX1 |
| T60529 | DI0207 | Indeterminate colitis | [ICD-11: DD72] | Q5T7T8 | COX1 |
| T60529 | DI0306 | Nutritional deficiency | [ICD-11: 5B50-5B71] | Q5T7T8 | COX1 |
| T60529 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | Q5T7T8 | COX1 |
| T60529 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | Q5T7T8 | COX1 |
| T60529 | DI0339 | Postoperative inflammation | [ICD-11: 1A00-CA43] | Q5T7T8 | COX1 |
| T60529 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q5T7T8 | COX1 |
| T60529 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | Q5T7T8 | COX1 |
| T60529 | DI0416 | Tuberculosis | [ICD-11: 1B10-1B12] | Q5T7T8 | COX1 |
| T60529 | DI0419 | Ulcerative colitis | [ICD-11: DD71] | Q5T7T8 | COX1 |
| T66665 | DI0087 | Chronic pain | [ICD-11: MG30] | P35354 | PTGS2 |
| T66665 | DI0145 | Female pelvic pain | [ICD-11: GA34] | P35354 | PTGS2 |
| T66665 | DI0188 | Hyper-lipoproteinaemia | [ICD-11: 5C80] | P35354 | PTGS2 |
| T66665 | DI0207 | Indeterminate colitis | [ICD-11: DD72] | P35354 | PTGS2 |
| T66665 | DI0227 | Knee osteoarthritis | [ICD-11: FA01] | P35354 | PTGS2 |
| T66665 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | P35354 | PTGS2 |
| T66665 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P35354 | PTGS2 |
| T66665 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P35354 | PTGS2 |
| T66665 | DI0416 | Tuberculosis | [ICD-11: 1B10-1B12] | P35354 | PTGS2 |
| T60857 | DI0145 | Female pelvic pain | [ICD-11: GA34] | P42330 | AKR1C3 |
| T98022 | DI0073 | Cerebral ischaemia | [ICD-11: 8B1Z] | Q96IY4 | CPB2 |
| T98022 | DI0074 | Cerebral ischaemic stroke | [ICD-11: 8B11] | Q96IY4 | CPB2 |
| T98022 | DI0405 | Thrombosis | [ICD-11: DB61-GB90] | Q96IY4 | CPB2 |
| T31956 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | Q07075 | ENPEP |
| T86591 | DI0187 | Hyperlipidemia | [ICD-11: 5C80] | Q07869 | PPARA |
| T86591 | DI0188 | Hyper-lipoproteinaemia | [ICD-11: 5C80] | Q07869 | PPARA |
| T86591 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | Q07869 | PPARA |
| T25608 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | O14842 | FFAR1 |
| T97071 | DI0122 | Diagnostic imaging | [ICD-11: N.A.] | Q04609 | FOLH1 |
| T97071 | DI0346 | Prostate cancer | [ICD-11: 2C82] | Q04609 | FOLH1 |
| T34234 | DI0083 | Chronic kidney disease | [ICD-11: GB61] | P11473 | VDR |
| T34234 | DI0171 | Hair/hair growth developmental defect | [ICD-11: LC30] | P11473 | VDR |
| T34234 | DI0189 | Hyper-parathyroidism | [ICD-11: 5A51] | P11473 | VDR |
| T34234 | DI0195 | Hypo-parathyroidism | [ICD-11: 5A50] | P11473 | VDR |
| T34234 | DI0266 | Mineral deficiency | [ICD-11: 5B5K] | P11473 | VDR |
| T34234 | DI0351 | Psoriasis | [ICD-11: EA90] | P11473 | VDR |
| T34234 | DI0437 | Vitamin deficiency | [ICD-11: 5B55-5B5F] | P11473 | VDR |
| T86273 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | Q8TDU6 | GPBAR1 |
| T06958 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P06746 | POLB |
| T39977 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P14174 | MIF |
| T13348 | DI0365 | Retinopathy | [ICD-11: 9B71] | P27695 | APEX1 |
| T13348 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P27695 | APEX1 |
| T07279 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | Q9P1W9 | PIM2 |
| T07279 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9P1W9 | PIM2 |
| T86057 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | Q96S37 | SLC22A12 |
| T61722 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | Q9Y5Y4 | PTGDR2 |
| T35640 | DI0351 | Psoriasis | [ICD-11: EA90] | P20701 | ITGAL |
| T35640 | DI0436 | Visual system disease | [ICD-11: 9E1Z] | P20701 | ITGAL |
| T49639 | DI0121 | Diabetic foot ulcer | [ICD-11: BD54] | P0DMV8 | HSPA1A |
| T49639 | DI0180 | Herpes simplex infection | [ICD-11: 1F00] | P0DMV8 | HSPA1A |
| T49639 | DI0231 | Leukaemia | [ICD-11: 2A60-2B33] | P0DMV8 | HSPA1A |
| T49639 | DI0244 | Malignant digestive organ neoplasm | [ICD-11: 2C11] | P0DMV8 | HSPA1A |
| T49639 | DI0260 | Metastatic malignant neoplasm | [ICD-11: 2D50-2E09] | P0DMV8 | HSPA1A |
| T49639 | DI0298 | Neuropathy | [ICD-11: 8C0Z] | P0DMV8 | HSPA1A |
| T49639 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P0DMV8 | HSPA1A |
| T49639 | DI0395 | Stomach cancer | [ICD-11: 2B72] | P0DMV8 | HSPA1A |
| T85421 | DI0125 | Dissociative neurological symptom disorder | [ICD-11: 6B60] | P53779 | MAPK10 |
| T40812 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | Q9UGN5 | PARP2 |
| T40812 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9UGN5 | PARP2 |
| T27889 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | Q9BYF1 | ACE2 |
| T27889 | DI0217 | Intrathoracic organs injury | [ICD-11: NB32] | Q9BYF1 | ACE2 |
| T27889 | DI0356 | Pulmonary hypertension | [ICD-11: BB01] | Q9BYF1 | ACE2 |
| T23499 | DI0070 | Cardiovascular disease | [ICD-11: BA00-BE2Z] | P25101 | EDNRA |
| T23499 | DI0356 | Pulmonary hypertension | [ICD-11: BB01] | P25101 | EDNRA |
| T23499 | DI0425 | Urinary system clinical symptom | [ICD-11: MF8Y] | P25101 | EDNRA |
| T68782 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | Q13258 | PTGDR |
| T78356 | DI0030 | Angina pectoris | [ICD-11: BA40] | P24557 | TBXAS1 |
| T07663 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | O76074 | PDE5A |
| T07663 | DI0213 | Innate/adaptive immunodeficiency | [ICD-11: 4A00] | O76074 | PDE5A |
| T07663 | DI0378 | Sexual dysfunction | [ICD-11: HA00-HA01] | O76074 | PDE5A |
| T07663 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | O76074 | PDE5A |
| T51565 | DI0104 | Coronavirus infection | [ICD-11: 1D92] | P68400 | CSNK2A1 |
| T51565 | DI0235 | Liver cancer | [ICD-11: 2C12] | P68400 | CSNK2A1 |
| T51565 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P68400 | CSNK2A1 |
| T81900 | DI0383 | Skin and skin-structure infection | [ICD-11: 1F28-1G0Z] | P14735 | IDE |
| T17852 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | O76083 | PDE9A |
| T17852 | DI0115 | Dementia | [ICD-11: 6D80-6D8Z] | O76083 | PDE9A |
| T17852 | DI0165 | Genitourinary disease | [ICD-11: GA0Z-GC8Z] | O76083 | PDE9A |
| T17852 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | O76083 | PDE9A |
| T17852 | DI0256 | Mental/behavioural/neurodevelopmental disorder | [ICD-11: 6E20-6E8Z] | O76083 | PDE9A |
| T17852 | DI0331 | Parkinsonism | [ICD-11: 8A00] | O76083 | PDE9A |
| T17852 | DI0370 | Schizophrenia | [ICD-11: 6A20] | O76083 | PDE9A |
| T17852 | DI0381 | Sickle-cell disorder | [ICD-11: 3A51] | O76083 | PDE9A |
| T97071 | DI0122 | Diagnostic imaging | [ICD-11: N.A.] | Q04609 | FOLH1 |
| T97071 | DI0346 | Prostate cancer | [ICD-11: 2C82] | Q04609 | FOLH1 |
| T70680 | DI0167 | Gout | [ICD-11: FA25] | Q4U2R8 | SLC22A6 |
| T70680 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | Q4U2R8 | SLC22A6 |
| T70680 | DI0310 | Ocular disease | [ICD-11: N.A.] | Q4U2R8 | SLC22A6 |
| T82078 | DI0346 | Prostate cancer | [ICD-11: 2C82] | O60603 | TLR2 |